$BMRA

Biomerica Inc

Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Irvine, CA

BMRA chart

What traders are saying about $BMRA

Latest posts

Biomerica Inc news

Biomerica Inc key financials

USD2025202420232022
Revenue$4.5M$5.3M$5.4M$5.3M
Net income-$3.8M-$5.0M-$6.0M-$7.1M
Diluted EPS$-1.30$-2.16$-2.84$-0.50
Total assets (year end)$6.0M$7.3M$11.8M$9.9M
Cash and equivalents (year end)$2.5M$2.4M$7.1M$5.1M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Biomerica Inc

Ticker
BMRA (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Irvine, CA
Incorporated in
DE
Fiscal year end
May 31
SEC CIK
73290

Frequently asked questions

What exchange is Biomerica Inc listed on?

Biomerica Inc trades on the Nasdaq under the ticker symbol BMRA.

What industry is Biomerica Inc in?

Biomerica Inc is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.

Where is Biomerica Inc headquartered?

Biomerica Inc's business address on file with the SEC is in Irvine, CA.

When does Biomerica Inc's fiscal year end?

Biomerica Inc's fiscal year ends on May 31.

How much revenue did Biomerica Inc report?

Biomerica Inc reported $4.5M in revenue for calendar year 2025, according to its SEC filings.